120 Carlton St, Buffalo, NY 14203, USA
For cancer patients in Upstate New York, Buffalo’s Roswell Park Cancer Institute (RPCI) may be the ideal choice for treatment. After all, this institution, established in 1898, was the nation’s first cancer research, treatment and education center. As the region’s only National Cancer Institute-designated Comprehensive Cancer Center, this hospital maintains the highest standards of excellence in patient care, education, basic science, clinical research and cancer prevention.
RPCI was founded on a multidisciplinary, collaborative approach to patient care and treatment, which is the standard for all modern-day comprehensive cancer centers. This certainly applies to lung cancer and associated diseases, as evidenced by the hospital’s Thoracic Program, a team of experts from RPCI providing comprehensive care for all types and stages of lung cancer. The program sees more than 400 inpatient admissions and 7,000 outpatient visits per year, with almost 600 new patients annually.
Among the multidisciplinary team’s lung cancer experts are Todd Demmy, M.D., clinical chair of the Department of Thoracic Surgery, with expertise in mesothelioma, lung and esophageal cancers – and research interests that include advanced minimally invasive thoracic surgical procedures, management of malignant pleural effusions and quality of life after thoracic surgery; and thoracic oncologist Sai Yendamuri, M.D., with expertise in mesothelioma and cancers of the esophagus and lungs.
With such a deadly disease, the best lung cancer treatment may be that of early detection, and that means that effective screening methods are crucial. The team’s tests include CT scans; bronchoscopy exams, which detect lung lesions or cancers; chest x-rays; and sputum samples. And as conventional therapies are typically ineffective for lung cancer, treatments may depend on specific disease types and stages. The leading procedures include:
The hospital’s dedication to cancer research has yielded grants and contracts totaling more than $104 million, and RPCI has sponsored or collaborated on more than 400 funded clinical trials. Besides being one of the first American hospitals to conduct Phase I cancer research studies, RPCI housed the nation’s first chemotherapy program. Additional achievements include those for surgical robotics, vitamin D research, immunotherapy and vaccine therapy and contributions to the Human Genome project.
RPCI currently spans 29 acres of the Buffalo Niagara Medical Center, consisting of 12 major buildings, including a facility dedicated to comprehensive diagnostic and treatments. This 133-bed hospital shares an academic affiliation with State University of New York at Buffalo. In 2010 alone, RPCI and its 12 multidisciplinary locations admitted almost 5,000 patients and treated about 200,000. The RPCI community of facilities employs 3,305 staff and faculty members, all of whom regularly participate in the hospital’s ongoing research programs.
View our resources for patients and familiesGet Help Today